Development of a PAK4-targeting PROTAC for renal carcinoma therapy: concurrent inhibition of cancer cell proliferation and enhancement of immune cell response

Shan Xu(Ministry of Education of the People's Republic of China), Lei Li(Ministry of Education of the People's Republic of China)
EBioMedicine
May 28, 2024
Cited by 20


Related Papers